Napsin A

Napsin A

Target · Aspartic protease

Napsin A Napsin A aspartic peptidase · Napsin-A

Napsin A (NAPSA) is a secreted aspartic protease of the peptidase A1 family, thought to take part in the processing of pneumocyte surfactant precursors. It is also known as NAP1, NAPA, Kdap and KAP, and it is described as a marker for lung adenocarcinoma and renal cell carcinoma. Browse Assay Genie's current range of Napsin A research reagents below, or read on for the biology behind the target.

Secreted proteinAspartic protease, peptidase A1Lung adenocarcinoma marker
420 aa
Protein length
~45 kDa
Molecular weight
19q13.33
Gene locus
EC 3.4.23.-
Enzyme class
Target information

What is Napsin A (napsin A aspartic peptidase)?

Napsin A is an aspartic protease that belongs to the peptidase A1 family. It may be involved in the processing of pneumocyte surfactant precursors, and the NCBI Gene summary suggests a role in the proteolytic processing of pulmonary surfactant protein B in the lung. The same summary proposes that it may function in protein catabolism in the renal proximal tubules. UniProt lists the mature protein as secreted.

The NAPSA gene encodes a preproprotein that is proteolytically processed to generate an activation peptide and the mature protease. The activation peptides of aspartic proteinases act as inhibitors of the protease active site. These pro-parts are considered important for correct folding, targeting and control of the activation of aspartic proteinase zymogens. Researchers working with the Napsin A protein therefore often consider both the zymogen and the mature form. The mouse ortholog is Napsa.

The Napsin A gene is also listed under the aliases NAP1, NAPA, Kdap, KAP and NR1H2-AS1, and HGNC places it in the peptidase family A1 gene group. It has been described as a marker for lung adenocarcinoma and renal cell carcinoma, which is why Napsin A antibody and Napsin A ELISA kit studies commonly appear in lung and kidney research.

Lung adenocarcinoma research

Napsin A has been described as a marker for lung adenocarcinoma, making it a point of reference in lung tumour studies.

Renal cell carcinoma studies

The gene has also been described as a marker for renal cell carcinoma, supporting work on kidney tumour biology.

Surfactant processing

Napsin A may be involved in processing pneumocyte surfactant precursors, including pulmonary surfactant protein B in the lung.

Aspartic protease zymogen biology

Its pro-part inhibits the active site and aids folding, targeting and activation control, a useful model for zymogen regulation.

Background

Napsin A frequently asked questions

What does Napsin A do?

Napsin A is an aspartic protease that may be involved in processing pneumocyte surfactant precursors. The NCBI Gene summary suggests it may process pulmonary surfactant protein B in the lung and may function in protein catabolism in the renal proximal tubules.

What other names does Napsin A have?

The official gene symbol is NAPSA, and HGNC names it napsin A aspartic peptidase. Aliases include NAP1, NAPA, Kdap, KAP and NR1H2-AS1. UniProt uses the protein name Napsin-A. The gene encodes a preproprotein that is processed into an activation peptide and the mature protease.

Is Napsin A linked to disease?

The NAPSA gene has been described as a marker for lung adenocarcinoma and renal cell carcinoma. Mouse studies can use the ortholog Napsa; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Surfactant proteins, other aspartic proteases and lung cancer markers that are related to Napsin A research.

Gene and protein annotations from HGNC, NCBI Gene and UniProt O96009; product specifications from Assay Genie datasheets.

Napsin A Product listing